Hospitalary Chronic Obstructive Pulmonary Disease Registry
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study is to create an institutional registry of Chronic Obstructive Pulmonary disease through a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2016
CompletedFirst Posted
Study publicly available on registry
January 20, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedAugust 13, 2019
August 1, 2019
3.4 years
January 5, 2016
August 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Death
All cause of death
At 6 months after enrollment
Secondary Outcomes (3)
Morbidity
At 6 months after enrollment
Functional decline (Forced expired volume at one second)
At 12 months after enrollment
Exacerbations (defined as an increase in symptoms that requires treatment)
At 12 months after enrollment
Eligibility Criteria
Patients older than 40 years with a chronic obstructive pulmonary disease diagnosis according to global initiative for chronic obstructive lung disease criteria.
You may qualify if:
- Patients older than 40 years with a chronic obstructive pulmonary disease diagnosis according to global obstructive lung Global initiative for chronic Obstructive Lung Disease criteria.
- Follow up at the Hospital Italiano de Buenos Aires.
You may not qualify if:
- Refusal to participate or to agree to the informed consent.
- Known non chronic obstructive pulmonary disease respiratory disease (ej: Lung Cancer, Tuberculosis, Pulmonary Fibrosis, Neumoconiosis, Cystic Fibrosis, Sarcoidosis, etc)
- Severe alpha-1 antitripsin deficit (typr SZ or ZZ)
- Previously thoracic surgery (ej: lung volume reduction, lung transplantation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Italiano de Buenos Aires, Peron 4190
Buenos Aires, Buenos Aires F.D., C1199ABB, Argentina
Related Publications (2)
Muiño Adriana, María Victoria López Varela, and Ana María Menezes. Prevalencia de la enfermedad pulmonar obstructiva crónica y sus principales factores de riesgo: proyecto platino en Montevideo. Revista Médica del Uruguay. 2005;21: 37-48
BACKGROUNDMoreira GL, Gazzotti MR, Manzano BM, Nascimento O, Perez-Padilla R, Menezes AM, Jardim JR. Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study. Sao Paulo Med J. 2015 May-Jun;133(3):245-51. doi: 10.1590/1516-3180.2015.9620902. Epub 2015 Jun 1.
PMID: 26176929BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego H Giunta, MD
Hospital Italiano de Buenos Aires
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2016
First Posted
January 20, 2016
Study Start
July 1, 2016
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
August 13, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share